iBio, Inc. (IBIO) — Analyst outlook / Analyst consensus target is. Based on 4 analyst ratings, the consensus is bullish — 3 Buy, 1 Hold.
The consensus price target is $2.00, representing a downside of 4.8% from the current price $2.10.
Analysts estimate Earnings Per Share (EPS) of $-7.41 and revenue of $0.00B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-6.50 vs est $-7.41 (beat +12.3%). 2025: actual $-1.75 vs est $-1.76 (beat +0.6%). Analyst accuracy: 93%.
IBIO Stock — 12-Month Price Forecast
$2.00
▼ -4.76% Downside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for iBio, Inc., the price target is $2.00.
The average price target represents a -4.76% change from the last price of $2.10.
IBIO Analyst Ratings
Buy
Based on 4 analysts giving stock ratings to iBio, Inc. in the past 3 months
EPS Estimates — IBIO
93%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$6.50
vs Est –$7.41
▲ 14.0% off
2025
Actual –$1.75
vs Est –$1.76
▲ 0.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — IBIO
43%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▲ 88.9% off
2025
Actual $0.000B
vs Est $0.000B
▲ 25.0% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
